Human Microbiome Market is Anticipated to Rise at an Impressive CAGR of 8.60% from 2018 to 2024

The human microbiome also known as microbiota is composed of population of microbes such as fungi, bacteria and archaea. These microbes reside on the surface or in the deep layers of skin in oral mucosa, the saliva, gastrointestinal tracts and in the conjunctiva. At present, extensive research is being conducted to discover the importance of these micro-organisms in maintaining immune systems and contributing to digestion of food.

Large number of microbes reside in the large intestine, with region of the human body having a distinct community of microbes dwelling. Studies are still in progress to understand the factors regulating microbial colonization in areas of the body that are just millimeters apart. The Human Microbiome Project (HMP) was launched in 2008 as a U.S. National Institute of Health. This was initiated with a goal of identifying and characterizing the microbes found within the healthy and diseases human body.

Obtain Report Details @ http://www.transparencymarketresearch.com/human-microbiome-market.html

This report on the global human microbiome market analyzes the future prospects of the market. The market for diagnostics and therapeutics is independently analyzed as two separate markets within the report. The market for microbiome therapeutics is segmented based on therapeutic area and region, while the market for microbiome diagnostics is segmented on the basis of indication, technology and region.

It comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. A detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2018 and 2024 for diagnostics and 2020 to 2024 for therapeutics, along with the compound annual growth rate (CAGR %) from 2018/20 to 2024 are provided for all the segments.

Market related factors such as new product launches, drugs in the pipeline, industry-institute collaborations in research for finding a pertinent cure, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global human microbiome market have been determined after a thorough analysis of past and present trends, demographics, future trends, technological developments, clinical trials, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Based on indication, the global human microbiome diagnostics market has been segmented into Gastrointestinal and Metabolic disorders, Women’s Health, Cancer and Others. Gastrointestinal & metabolic disorders are likely to show most promising growth in the market owing to the higher unmet medical need for gut health disorders as well as a rise in population suffering from faulty- lifestyle based metabolic diseases.

Based on technology, the market has been segmented into 16s rRNA sequencing and metagenomic sequencing. Both the forms have been documented to have various advantages with regard to accurate testing and hence, both these segments garner nearly equal share of the overall diagnostics market during the forecast period. Based on therapeutic area, the market has been segmented into Gastrointestinal Disorders, Metabolic disorders, Women’s Health, Skin Disorders and Others. Other therapeutic areas include autoimmune disorders, infant health disorders, and rare diseases.

Fill the form to gain deeper insights on this market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3999

Geographically, the global human microbiome market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries. These include the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, the UAE, and South Africa. The competition landscape section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the human microbiome market.

The report profiles major players in the human microbiome market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include AOBiome LLC, Osel Inc., Seres Therapeutics, Second Genome, uBiome Inc., Metabiomics Corp., Rebiotix Inc., Vedanta Biosciences etc.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.